Omnia Ibrahim, Author at Labiotech.eu

Diving deep into science: How the life science industry relies on CRO’s drug hunter skills

Over the years, CROs have evolved from a transactional ‘pair of hands’ to organizations that are true partners in their client’s drug discovery journey, providing them with cutting edge science…

December 20, 2022 - 7 minutesmins - By Omnia Ibrahim

Interview 18 Nov 2022

How cardioids can usher in the next generation of drug discovery

The California-based Molecular Devices brings automated 3D cell culture and image analysis together with HeartBeat.bio’s cardioid technology to enable unique and scalable drug discovery and cardiac safety testing. Cardiovascular diseases…

November 18, 2022 - 6 minutesmins - By Omnia Ibrahim

Best in Biotech 4 Nov 2022

Get to know 15 of the best biotech companies in Paris

Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In this guide, we explore 15 interesting biotech companies in Paris. Paris is one of the…

November 4, 2022 - 11 minutesmins - By Omnia Ibrahim

Interview 28 Oct 2022

Migraines: a new vaccine frontier beyond infectious diseases

By bringing the efficiency and affordability of vaccines to chronic diseases such as migraines, U.S. company Vaxxinity aims to open a new frontier for vaccines in an effort to reach…

October 28, 2022 - 7 minutesmins - By Omnia Ibrahim

Interview 27 Sep 2022

Europe’s first lab-grown fish company Bluu Seafood is aiming for sustainability

Overfishing is a global issue that negatively impacts the ecosystem and our access to fish protein. One solution to overfishing is producing fish products in the lab from harvested animal…

September 27, 2022 - 5 minutesmins - By Omnia Ibrahim

Best in Biotech 25 Aug 2022

Five cleantech companies making New Zealand more green

Cleantechs are focused on reducing negative environmental impacts by offering recycling, renewable energy, green chemistry solutions and more. From extracting gold from old electronics to seaweed supplements for cattle, here…

August 25, 2022 - 4 minutesmins - By Omnia Ibrahim

Interview 19 Aug 2022

How re-engineering antibodies can prevent allergies

The California startup IgGenix is aiming to re-engineer antibodies that mediate allergic responses into antibodies that can block this response. We spoke with IgGenix’s CEO Jessica Grossman and CTO Derek…

August 19, 2022 - 9 minutesmins - By Omnia Ibrahim

Best in Biotech 19 Aug 2022

Five emerging biotech hubs in the Asia-Pacific region

The Asia-Pacific (APAC) region is the third largest pharmaceutical market in the world, and has seen a shift from predominantly producing generics to developing innovative technologies. Here are five emerging…

August 19, 2022 - 7 minutesmins - By Omnia Ibrahim

Best in Biotech 11 Aug 2022

10 biotech companies to know in Taiwan

With pipelines including botanical drugs and fat-reducing injections to monoclonal antibodies for HIV, here are 10 innovative biotech companies in Taiwan. Taiwan is recognized as a global leader in the…

August 11, 2022 - 7 minutesmins - By Omnia Ibrahim

Best in Biotech 28 Jul 2022

Five companies personalizing treatments with 3D printed drugs

There has been a noticeable shift in recent years towards the personalization of medicine, with the pharmaceutical industry showing interest in pills that are tailored to a patient’s needs. Here…

July 28, 2022 - 5 minutesmins - By Omnia Ibrahim

In Depth 26 Jul 2022

How DNA sequencing can safeguard against biodiversity loss

Preserving Earth’s biodiversity is crucial as we rely on healthy ecosystems for many services, from clean air and water to protection from floods and pandemics. DNA sequencing is an invaluable…

July 26, 2022 - 8 minutesmins - By Omnia Ibrahim

News and Trends 15 Jul 2022

Triastek forms pact with Eli Lilly to 3D print tablets for oral drug delivery

A new research collaboration between Triastek, Inc. and Eli Lilly and Company will leverage 3D printing technology to achieve precise targeting and programmed drug release in the intestine. The China-based…

July 15, 2022 - 3 minutesmins - By Omnia Ibrahim

News and Trends 15 Jul 2022

WHO and UNICEF sound the alarm as global vaccination coverage continues to decline

Amid worldwide disruptions caused by the COVID-19 pandemic, WHO and UNICEF report the largest continued backslide in childhood vaccinations in approximately three decades, with 25 million infants missing out on…

July 15, 2022 - 4 minutesmins - By Omnia Ibrahim

researchers in lab; biotech collaboration

News and Trends 14 Jul 2022

GenScript ProBio enters strategic partnerships with two South Korean biotechs

GenScript ProBio, the CDMO segment of the leading biotech GenScript, has entered into a strategic partnership memorandum of understanding (MOU) with DAAN Bio Therapeutics for the discovery and development of…

July 14, 2022 - 3 minutesmins - By Omnia Ibrahim

covid-19 vaccine emergency use authorization

News and Trends 14 Jul 2022

FDA authorizes the first protein-based COVID-19 vaccine in the US

Novavax, Inc. has been given emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) for its adjuvanted, protein-based COVID-19 shot. Branded Nuvaxovid and Covovax outside the U.S.,…

July 14, 2022 - 2 minutesmins - By Omnia Ibrahim

Best in Biotech 29 Jun 2022

7 biotech books to dive into this summer

From the unprecedented speed at which the COVID-19 vaccines were developed to the biggest fraud case in biotech history, to a sci-fi story set in a post-apocalyptic city, here are…

June 29, 2022 - 6 minutesmins - By Omnia Ibrahim

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering